148 related articles for article (PubMed ID: 8252489)
1. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S
Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489
[TBL] [Abstract][Full Text] [Related]
2. Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis.
Matsuzaki A; Inamitsu T; Watanabe T; Ohga S; Ishii E; Nagotoshi Y; Tasaka H; Suda M; Ueda K
Br J Haematol; 1994 Apr; 86(4):887-9. PubMed ID: 7918090
[TBL] [Abstract][Full Text] [Related]
3. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans' cell histiocytosis.
López-Andreu JA; Ferris J; Verdeguer A; Esquembre C; Castel V
Cancer; 1994 Sep; 74(5):1650-2. PubMed ID: 7864932
[No Abstract] [Full Text] [Related]
4. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
Egeler RM
Cancer; 1995 Jan; 75(1):134-6. PubMed ID: 7804969
[No Abstract] [Full Text] [Related]
5. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations.
Haupt R; Fears TR; Heise A; Gadner H; Loiacono G; De Terlizzi M; Tucker MA
Int J Cancer; 1997 Mar; 71(1):9-13. PubMed ID: 9096658
[TBL] [Abstract][Full Text] [Related]
6. Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH).
Lopes LF; de Camargo B
Med Pediatr Oncol; 1999 Apr; 32(4):315. PubMed ID: 10102032
[No Abstract] [Full Text] [Related]
7. Langerhans cell histiocytosis and acute leukemia: unusual association in two cases.
Aricò M; Comelli A; Bossi G; Raiteri E; Piombo M; Egeler RM
Med Pediatr Oncol; 1993; 21(4):271-3. PubMed ID: 8469222
[TBL] [Abstract][Full Text] [Related]
8. [Therapy-related acute promyelocytic leukemia with a t(9;22)(q34;q11) and t(15;17)(q22;q11 to approximately 12) subclone].
Mochiduki Y; Muramoto S
Rinsho Ketsueki; 2005 Nov; 46(11):1218-22. PubMed ID: 16440807
[TBL] [Abstract][Full Text] [Related]
9. Etoposide-related acute promyelocytic leukemia.
Kudo K; Yoshida H; Kiyoi H; Numata S; Horibe K; Naoe T
Leukemia; 1998 Aug; 12(8):1171-5. PubMed ID: 9697869
[TBL] [Abstract][Full Text] [Related]
10. Acute leukemia in association with Langerhans cell histiocytosis.
Egeler RM; Neglia JP; Aricò M; Favara BE; Heitger A; Nesbit ME
Med Pediatr Oncol; 1994; 23(2):81-5. PubMed ID: 8202046
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of the t(15;17) translocation in de novo and secondary acute promyelocytic leukemia.
Naoe T; Kudo K; Yoshida H; Horibe K; Ohno R
Leukemia; 1997 Apr; 11 Suppl 3():287-8. PubMed ID: 9209367
[TBL] [Abstract][Full Text] [Related]
12. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS
Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031
[TBL] [Abstract][Full Text] [Related]
13. Secondary acute promyelocytic leukemia following chemotherapy for non-Hodgkin's lymphoma in a child.
Ogami A; Morimoto A; Hibi S; Todo S; Sugimoto T; Mori K; Imamura T; Ishida H; Yoshihara T; Iguchi A; Imaizumi M; Imashuku S
J Pediatr Hematol Oncol; 2004 Jul; 26(7):427-30. PubMed ID: 15218416
[TBL] [Abstract][Full Text] [Related]
14. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
[TBL] [Abstract][Full Text] [Related]
15. Translocation (11;11)(p13- p15;q23) in a child with therapy-related acute myeloid leukemia following chemotherapy with DNA-topoisomerase II inhibitors for Langerhans cell histiocytosis.
Silva ML; Land MG; Maradei S; Otero L; Veith M; Brito G; Klumb C; Fernandez T; Pombo-de-Oliveira MS
Cancer Genet Cytogenet; 2002 May; 135(1):101-2. PubMed ID: 12072208
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis.
Haupt R; Fears TR; Rosso P; Colella R; Loiacono G; de Terlizzi M; Mancini A; Comelli A; Indolfi P; Donfrancesco A
Pediatr Hematol Oncol; 1994; 11(5):499-507. PubMed ID: 7826846
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India.
Narula G; Pradhan ND; Arora B; Banavali SD
Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864
[TBL] [Abstract][Full Text] [Related]
18. Etoposide in Langerhans cell histiocytosis in children: a preliminary experience.
Basade MM; Nair CN; Kurkure PA; Pai SK; Advani SH
Pediatr Hematol Oncol; 1996; 13(2):159-62. PubMed ID: 8721030
[TBL] [Abstract][Full Text] [Related]
19. [Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
Su Y; Zhou X; Zhang L; Zhang R
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):938-42. PubMed ID: 24495767
[TBL] [Abstract][Full Text] [Related]
20. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.
Minkov M
Paediatr Drugs; 2011 Apr; 13(2):75-86. PubMed ID: 21351807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
